Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation
- Conditions
- Arrhythmias
- Interventions
- Device: AmigoDevice: Manual ablation
- Registration Number
- NCT01834872
- Lead Sponsor
- Instituto de Investigación Sanitaria Gregorio Marañón
- Brief Summary
The aim of this prospective observational study is to evaluate the performance of Amigo RCS in ablation procedures for most common arrhythmias as compared to a conventional manual approach.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Patients referred to our electrophysiology laboratory to treat any type of arrhythmia with catheter ablation
- NA
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Amigo Amigo Ablation completed with Amigo Manual Manual ablation Ablation completed with manual catheter
- Primary Outcome Measures
Name Time Method Ablation Success 1 year Global efficacy:
Recurrence rate Re-do procedures Proportion of patients under anti arrhythmic treatmentSafety Endpoint 1 Year Any complications that could be attributed to the procedure during follow-up.
- Secondary Outcome Measures
Name Time Method Acute Ablation Success During Procedure Accessory pathway: Anterograde and retrograde conduction block through the accessory Pathway Atrial fibrillation: % patients with all PV disconnected circumferential ablation with electrical disconnection of all pulmonary veins Common-type atrial flutter: Bidirectional cavotricuspid isthmus block AVNRT/Ventricular tachycardia/other atrial arrhythmias: Arrhythmia termination / absence o induction
Acute Safety Endpoint During Procedure Procedure complications: Any complication during the electrophysiological procedure and 1 week post ablation that could be attributed to the procedure: Vascular complication, pericardial effusion/cardiac tamponade, heart failure, others.
The number of adverse events will be collected.
Trial Locations
- Locations (1)
Hospital General Universitario Gregorio Marañón
🇪🇸Madrid, Spain